Overview

The Effects of GLP-1 in Maturity-Onset Diabetes of The Young (MODY)

Status:
Completed
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the treatment potential of GLP-1-analogues in patients with Maturity Onset Diabetes of the Young (MODY) compared to common treatment.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
University Hospital, Gentofte, Copenhagen
Collaborators:
Novo Nordisk A/S
University of Copenhagen
Treatments:
Glimepiride
Liraglutide